|
HYPAQUE
|
6505-01-068-8651
|
Diatrizoate Meglumine Injection |
Sterling-winthrop Research Institute
|
|
Quote
|
|
NDC0003-0696-55
|
6505-01-068-8651
|
Diatrizoate Meglumine Injection |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC0024-0747-02
|
6505-01-068-8651
|
Diatrizoate Meglumine Injection |
Sterling-winthrop Research Institute
|
|
Quote
|
|
BENYLIN
|
6505-01-068-8652
|
Diphenhydramine Hydrochloride Sy |
Parke-davis
|
|
Quote
|
|
NDC00005-3243-65
|
6505-01-068-8652
|
Diphenhydramine Hydrochloride Sy |
American Cyanamid Co
|
|
Quote
|
|
NDC00071-2195-23
|
6505-01-068-8652
|
Diphenhydramine Hydrochloride Sy |
Parke-davis
|
|
Quote
|
|
12-8120-3
|
6505-01-068-8653
|
Concentrat Hemodialysis Solution |
National Medical Care
|
|
Quote
|
|
ERI-LYTE 8120
|
6505-01-068-8653
|
Concentrat Hemodialysis Solution |
National Medical Care
|
|
Quote
|
|
QUINAGLUTE DURA-TAB
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00005-3113-48
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
American Cyanamid Co
|
|
Quote
|
|
NDC50419-0101-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00591-5538-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Danbury Pharmacal Inc
|
|
Quote
|
|
QUINAGLUTE DURA-TAB
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC50419-0101-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00591-5538-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Danbury Pharmacal Inc
|
|
Quote
|
|
NDC00005-3113-48
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
American Cyanamid Co
|
|
Quote
|
|
QUINAGLUTE DURA-TAB
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC50419-0101-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00591-5538-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Danbury Pharmacal Inc
|
|
Quote
|
|
NDC00005-3113-48
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
American Cyanamid Co
|
|
Quote
|
|
QUINAGLUTE DURA-TAB
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC50419-0101-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00591-5538-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Danbury Pharmacal Inc
|
|
Quote
|
|
NDC00005-3113-48
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
American Cyanamid Co
|
|
Quote
|
|
QUINAGLUTE DURA-TAB
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC50419-0101-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00591-5538-12
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
Danbury Pharmacal Inc
|
|
Quote
|
|
NDC00005-3113-48
|
6505-01-069-3244
|
Quinidine Gluconate Extended-rel |
American Cyanamid Co
|
|
Quote
|
|
NDC51079-0630-20
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00663-4310-41
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Pfizer Inc.
|
|
Quote
|
|
NDC51079-0630-20
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00663-4310-41
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Pfizer Inc.
|
|
Quote
|
|
NDC51079-0630-20
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00663-4310-41
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Pfizer Inc.
|
|
Quote
|
|
NDC51079-0630-20
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00663-4310-41
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Pfizer Inc.
|
|
Quote
|
|
NDC51079-0630-20
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00663-4310-41
|
6505-01-069-3247
|
Prazosin Hydrochloride Capsules |
Pfizer Inc.
|
|
Quote
|
|
NDC51079-0631-20
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00364-2390-90
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC51079-0631-20
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00364-2390-90
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC51079-0631-20
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00364-2390-90
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC51079-0631-20
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00364-2390-90
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC51079-0631-20
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00364-2390-90
|
6505-01-069-3248
|
Prazosin Hydrochloride Capsules |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC54569-0559-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00378-0183-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00591-5555-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Danbury Pharmacal Inc
|
|
Quote
|
|
NDC54868-0293-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Medical and Safety Group Inc
|
|
Quote
|
|
NDC00603-5490-32
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00904-0412-80
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC00536-4313-10
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00364-0757-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Schein Henry Inc
|
|
Quote
|
|
NDC00364-0757-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Henry Schein, Inc.
|
|
Quote
|
|
NDC00378-0183-10
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
The Fenway Group Llc
|
|
Quote
|
|
NDC50111-0468-03
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC50111-0468-03
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00378-0183-01
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-0183-10
|
6505-01-069-4363
|
Propranolol Hydrochloride Tablet |
The Fenway Group Llc
|
|
Quote
|
|
HALOG SOLUTION
|
6505-01-069-6260
|
Usp Halcinonide Topical Solution |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0249-20
|
6505-01-069-6260
|
Usp Halcinonide Topical Solution |
Squibb E R and Sons Inc
|
|
Quote
|
|
OS-CAL 500 TABLETS
|
6505-01-069-6261
|
Usp Calcium Carbonate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
OYSCO 500
|
6505-01-069-6261
|
Usp Calcium Carbonate Tablets |
Rugby Group Inc
|
|
Quote
|
|
NDC00088-1651-41
|
6505-01-069-6261
|
Usp Calcium Carbonate Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00088-1651-41
|
6505-01-069-6261
|
Usp Calcium Carbonate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00182-1576-26
|
6505-01-069-6261
|
Usp Calcium Carbonate Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00536-4106-08
|
6505-01-069-6261
|
Usp Calcium Carbonate Tablets |
Rugby Group Inc
|
|
Quote
|
|
LIMBITROL 10-25
|
6505-01-069-6514
|
Chlordiazepoxide And Amitriptyli |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
LIMBITROL
|
6505-01-069-6514
|
Chlordiazepoxide And Amitriptyli |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
LIMBITROL TABLETS
|
6505-01-069-6514
|
Chlordiazepoxide And Amitriptyli |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00140-0071-01
|
6505-01-069-6514
|
Chlordiazepoxide And Amitriptyli |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC61314-0226-05
|
6505-01-069-6518
|
Timolol Maleate Ophthalmic Solut |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC61314-0227-05
|
6505-01-069-6519
|
Timolol Maleate Ophthalmic Solut |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC60758-0801-05
|
6505-01-069-6519
|
Timolol Maleate Ophthalmic Solut |
Pacific Pharma Inc
|
|
Quote
|
|
NDC50111-0459-03
|
6505-01-069-6520
|
Theophylline Extended-release Ta |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
H-1000
|
6505-01-069-6528
|
Mod Sterile Water For Inhalation |
B Braun Medical Inc
|
|
Quote
|
|
THEO-DUR TABLETS
|
6505-01-070-0821
|
Theophylline Extended-release Ta |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-0933-10
|
6505-01-070-0821
|
Theophylline Extended-release Ta |
Schering-plough Corporation
|
|
Quote
|
|
NDC00085-0933-10
|
6505-01-070-0821
|
Theophylline Extended-release Ta |
Schering Corp
|
|
Quote
|
|
NDC00258-3583-10
|
6505-01-070-0821
|
Theophylline Extended-release Ta |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
0596-41
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-0596-41
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
MEGACE
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00182-1864-89
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Ivax
|
|
Quote
|
|
NDC00904-3571-61
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC49884-0290-01
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Par Pharmaceutical, Inc.
|
|
Quote
|
|
NDC00054-4604-25
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00054-8604-25
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00555-0607-02
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Barr Laboratories, Inc.
|
|
Quote
|
|
NDC00182-1864-01
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC51079-0435-20
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00093-0674-01
|
6505-01-070-1493
|
Usp Megestrol Acetate Tablets |
Lemmon Co
|
|
Quote
|
|
NDC00314-0607-70
|
6505-01-070-1525
|
Usp Atropine Sulfate Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00555-0635-02
|
6505-01-070-1634
|
Usp Danazol Capsules |
Barr Laboratories, Inc.
|
|
Quote
|
|
D226
|
6505-01-070-1634
|
Usp Danazol Capsules |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-0305-06
|
6505-01-070-1634
|
Usp Danazol Capsules |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-0305-06
|
6505-01-070-1634
|
Usp Danazol Capsules |
Sterling-winthrop Research Institute
|
|
Quote
|
|
VOSOL HC OTIC SOLUTION
|
6505-01-070-2782
|
Benzethonium Glacial Acetic Acid |
Baylor Laboratories Inc
|
|
Quote
|
|
C035
|
6505-01-070-2782
|
Benzethonium Glacial Acetic Acid |
Defense Logistics Agency
|
|
Quote
|
|
NDC0252-2066-01
|
6505-01-070-5177
|
Aminoacetic Acid And Calcium Car |
Dept of Health Education and Welfare
|
|
Quote
|
|
NDC00054-3408-40
|
6505-01-070-5807
|
Isoetharine Inhalation Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC0074-4888-10
|
6505-01-071-0205
|
Usp Sodium Chloride Injection |
Abbott Laboratories Abbott
|
|
Quote
|
|
QUINAGLUTE DURA-TAB
|
6505-01-071-2521
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00005-3113-42
|
6505-01-071-2521
|
Quinidine Gluconate Extended-rel |
American Cyanamid Co
|
|
Quote
|
|
NDC50419-0101-09
|
6505-01-071-2521
|
Quinidine Gluconate Extended-rel |
Bayer Healthcare Pharmaceuticals
|
|
Quote
|
|
NDC00591-5538-90
|
6505-01-071-2521
|
Quinidine Gluconate Extended-rel |
Danbury Pharmacal Inc
|
|
Quote
|
|
AQUAPAK 700
|
6505-01-071-2522
|
Usp Sterile Water For Inhalation |
Respiratory Care Inc
|
|
Quote
|
|
037-00
|
6505-01-071-2522
|
Usp Sterile Water For Inhalation |
Respiratory Care Inc
|
|
Quote
|
|
CLINORIL TABLETS
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00005-3550-43
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Lederle Laboratories Div of American
|
|
Quote
|
|
NDC00781-1811-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Sandoz Inc.
|
|
Quote
|
|
NDC53489-0478-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Mutual Pharmaceutical Company, Inc.
|
|
Quote
|
|
NDC00677-1173-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00378-0427-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00591-5661-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Danbury Pharmacal Inc
|
|
Quote
|
|
NDC51079-0666-20
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00006-0941-68
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
3360
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00591-5661-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Actavis Pharma, Inc.
|
|
Quote
|
|
NDC00378-0427-01
|
6505-01-071-5559
|
Usp Sulindac Tablets |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
